Literature DB >> 30536872

Eight-week interval in flushing and locking port-a-cath in cancer patients: A single-institution experience and systematic review.

Carla Fornaro1, Maria Piubeni1, Valeria Tovazzi1, Deborah Cosentini1, Maria Gelmi1, Gabriella Rota1, Barbara Berta1, Wilma Barucco1, Eleonora Lombardi1, Luisa Moles1, Tiziana Faustini1, Tiziana Fettolini1, Paolo Motta2, Vittorio D Ferrari1, Alfredo Berruti1, Elisabetta Conti1.   

Abstract

Port-a-cath (PAC) system is one of the most frequently employed venous accesses for administration of chemotherapy and supportive care. To prevent late complications, the latest guidelines recommend flushing/locking procedures every four weeks. In this retrospective study, we evaluate the frequencies of late complications with a eight-week flushing/locking procedure compared to the standard one. This study retrospectively compares the frequency of complications occurred using standard versus delayed flushing schedules. We performed a systematic review of the published studies about PAC complications associated with longer flushing intervals. Three hundred and ninety fully available patients were enrolled. One hundred and six patients had their PAC flushed/locked every month, 347 patients performed the flushing/locking procedures every eight weeks, 63 patients switched from the four to the eight-week schedule. No difference was seen in the number of occlusions, infections and mechanical dysfunctions between the two patient groups. The systematic literature review confirmed, in a total of 1,347 patients, the absence of an increased proportion of complications with delayed schedules. PAC flushing and locking every eight weeks are feasible and safe. This delayed schedule may improve patients' quality of life and decrease both nursing workload and costs for the national health system.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  PAC; cancer patients; complications; flushing; timing; venous access

Mesh:

Substances:

Year:  2018        PMID: 30536872     DOI: 10.1111/ecc.12978

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  1 in total

1.  Evidence on port-locking with heparin versus saline in patients with cancer not receiving chemotherapy: A randomized clinical trial.

Authors:  Melania Cia-Arriaza; Sandra Cabrera-Jaime; Rosario Cano-Soria; Mireia Manzano-Castro; Margarita Domínguez-Gómez; Dolores M Prieto-Arenas; Angeles Benito-Yagüe; Adela Sánchez-Martín; Cristina González-Alonso; Paz Fernández-Ortega
Journal:  Asia Pac J Oncol Nurs       Date:  2022-05-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.